期刊文献+

肠易激综合征患者肠道黏膜炎症与精神障碍的关系 被引量:15

Relationship between intestinal mucosal inflammation and mental disorders in patients with irritable bowel syndrome
原文传递
导出
摘要 目的比较肠易激综合征(IBS)伴精神障碍与不伴精神障碍患者的肠道黏膜炎症指标,了解炎症与IBS精神障碍共病的关系。方法顺序纳入2008年11月至2011年3月在北京大学第三医院消化科门诊就诊、符合罗马Ⅲ标准的IBS患者43例及无消化道症状的志愿者(对照组)15名,由经过培训的人员应用复合性国际诊断交谈表(CIDI)对其进行访谈;所有纳入者行结肠镜检查并取回肠末端和结肠黏膜活检组织,比较IBS不伴精神障碍(24例)及伴精神障碍(19例)患者与对照组(13名,有精神障碍者2例予以剔除)的肠黏膜活检组织CD3阳性淋巴细胞、肥大细胞、5-羟色胺阳性细胞及吲哚胺2,3.双加氧酶(IDO)阳性细胞数。结果IBS患者中任意精神障碍检出比例显著高于对照组(19/43比2/15,P=0.012),其中焦虑障碍9例,心境障碍8例。IBS伴精神障碍患者在回肠末端、乙状结肠黏膜组织的肥大细胞数及5.羟色胺阳性细胞数(每高倍视野:16.7±3.6、12.8±2.2,3.7±0.9、6.1±1.8),与IBS不伴精神障碍组(每高倍视野:15.4±3.1、12.3±2.5,3.4±0.8、5.2±1.8)相比,差异均无统计学意义(均P〉0.05);回肠末端CD3阳性淋巴细胞、IDO阳性细胞数与IBS不伴精神障碍组差异亦均无统计学意义(均P〉0.05)。IBS伴焦虑障碍患者的回肠末端IDO计数显著高于IBS不伴精神障碍患者[中位数(Q1,Q3):6(4,8)比2(1,5),P=0.018]。IBS伴心境障碍患者的回肠末端肥大细胞计数显著高于IBS不伴精神障碍组(每高倍视野:18.3±3.2比15.4±3.1,P=0.032)。结论IBS患者精神障碍可能与肠道黏膜炎症有一定关系;IDO激活可能与焦虑障碍共病,肥大细胞活化可能与心境障碍共病相关。 Objective To examine the relationship between inflammation and the comorbidity of mental disorders with irritable bowel syndrome (IBS) by comparing intestinal mucosa inflammatory biomarkers in patients with and without mental disorders. Methods A total of 43 consecutive IBS patients fulfilling the Rome Ⅲ criteria and 15 volunteers serving as controls without digestive symptoms were recruited and interviewed with Composite International Diagnostic Interview (CIDI) by the well-trained staff and thus classified as with or without mental disorders. All subjects underwent colonoscopy and biopsies were acquired from the mucosa of distal ileum and colon. CD3 + lymphocytes, mast cells, 5-HT positive cells and (indoleamine 2,3-dioxygenase) IDO positive cells were identified immunohistologically in mucosa biopsies in volunteers (n = 13 ), IBS patients without mental disorder (n = 24) and IBS patients with mental disorder (n = 19). Results The incidence of mental disorders in IBS patients was significantly higher than that in the volunteers (19/43 vs 2/15, P = 0. 012) , including 9 patients with anxiety disorders and 8 with mood disorders. ( 1 ) The number of mast cells in IBS patients with mental disorder and that in IBS patients without mental disorder has no statistical significance ( ( 16. 7 ± 3.6 )/HP vs ( 15.4 ± 3.1 )/HP in distal ileum, ( 12. 8 ± 2. 2)/HP vs ( 12. 3 ± 2. 5 )/HP in sigmoid, both P 〉 0. 05 ). Similar results were seen in 5-HT positive cells( (3.7 ±0. 9)/HP vs(3.4 ±0. 8)/HP in distal ileum, (6. 1 ±1.8)/HP vs(5.2 ± 1.8)/HP in sigmoid, both P 〉 0. 05 ). In distal ileum, the number of CD3+ cells in IBS patients with mental disorder has no statistical significance with that in the IBS patients without mental disorder ( (62 ± 16)/HP vs (55± 22)/HP, P 〉 0. 05 ). Similar results were seen in IDO positive cells (6 (2,8)/HP vs 2 ( 1,5 )/HP, P 〉 0. 05). (2) The number of IDO positive cells from distal ileum in IBS patients with anxiety disorder was significantly higher than that in the IBS patients without mental disorder ( 6 (4, 8 ) vs 2 ( 1, 5 ), P = 0. 018 ). The number of mast cells from distal ileum in the IBS patients with mood disorder were significantly higher than that in those without mental disorders ( ( 18.3± 5.2 )/HP vs ( 15.4 ± 3.1 )/HP, P = 1. 032 ). Conclusions Mental disorders in the IBS patients may be associated with intestinal mucosal inflammation. The activation of IDO may cause the comorbidity of IBS with anxiety disorder while the activation of mast ceils nrobablv leads to the comorbiditv of IBS with mood disorder.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第32期2247-2251,共5页 National Medical Journal of China
基金 国家高技术研究发展计划(863计划)(2007AA022423)
关键词 肠易激综合征 精神障碍 共病现象 复合性国际诊断交谈表(CIDI) Irritable bowel syndrome Mental disorders Comorbidity Compositeinternational diagnostic interview
  • 相关文献

参考文献19

  • 1Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry, 2011, 35:664-675.
  • 2Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry, 2010, 67: 446-457.
  • 3Kim YK, Jung HG, Myint AM, et al. Imbalance between pro- inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord, 2007, 104:91-95.
  • 4Maes M, Song C, Lin A, et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Thl-like response in stress-induced anxiety. Cytokine, 1998, 10:313-318.
  • 5Swardfager W, Herrmann N, Dowlati Y, et al. Indoleamine 2,3- dioxygenase activation and depressive symptoms in patients with coronary artery disease. P 1560-1566.
  • 6O'Connor JC, Lawson MA, Andre C, et al. Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol, 2009, 182:3202-3212.
  • 7Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res, 1996, 711:163-174.
  • 8Scully P, Mckernan DP, Keohane J, et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra- intestinal co-morbidity. Am J Gastmenteml, 2010, 105 : 2235 -2243.
  • 9郝靖欣,韩麦,段丽萍,葛颖,黄悦勤.医院就诊肠易激综合征患者精神障碍共病的临床观察[J].中华医学杂志,2011,91(27):1886-1890. 被引量:16
  • 10Yamazaki F, Kuroiwa T, Takikawa O, et al. Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem J, 1985, 230:6354538.

二级参考文献21

  • 1石其昌,章健民,徐方忠,费立鹏,许毅,傅永利,顾卫,周夏江,王淑敏,张滢,俞敏.浙江省15岁及以上人群精神疾病流行病学调查[J].中华预防医学杂志,2005,39(4):229-236. 被引量:299
  • 2位照国,王希林,孙旭坤,李涛,康岚,王雪琴.综合医院住院病人躯体形式障碍的临床特点[J].中国心理卫生杂志,2006,20(3):183-185. 被引量:37
  • 3李江雪,项锦晶.人格诊断问卷(PDQ-4+)在研究生群体中的应用研究[J].中国临床心理学杂志,2006,14(6):580-582. 被引量:14
  • 4Maxion-Bergemann S, Thielecke F, Abel F, et al. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics, 2006,24:21-37.
  • 5Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepato1,2009,24 : 1601-1607.
  • 6Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05 : an epidemiological survey. Lancet, 2009, 373 : 2041-2053.
  • 7Jones MP, Crowell MD, Olden KW, et al. Functional gastrointestinal disorders : an update for the psychiatrist. Psychosomatics, 2007,48 : 93 - 102.
  • 8Hillila MT, Siivola MT, Farkkila MA. Comorbidity and use of health-care services among irritable bowel syndrome sufferers. Scand J Gastroenterol,2007 ,42 :799-806.
  • 9Hu WH, Wong WM, Lam CL, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome:a population-based study. Aliment Pharmacol Ther,2002,16 : 2081-2088.
  • 10Creed F. The relationship between psychosocial parameters and outcome in irritable bowel syndrome. Am J Med, 1999, 107: 74S-80S.

共引文献15

同被引文献153

引证文献15

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部